CAO, M. et al. The Efficacy and Safety of Empagliflozin in Elderly Patients with Type 2 Diabetes Mellitus Complicating Cardiorenal Syndromes Type II and IV: Evaluation of Empagliflozin in CRS. Journal of Medical Biochemistry, v. 44, n. 4, p. 905–914, 28 Apr.2025.